Cedars-Sinai launches gastrointestinal research initiative: 4 notes

Los Angeles-based Cedars-Sinai Medical Center launched the Medically Associated Science and Technology program to advance treatments for gastrointestinal and metabolic disorders.

Here are four things to know:

1. MAST investigators are currently focusing on areas of the microbiome linked to irritable bowel syndrome and small intestinal bacterial overgrowth.

2. The Cedars-Sinai Technology Transfer Office and the Burns & Allen Research Institute at Cedars-Sinai partnered to create the program.

3. Since its inception, MAST researchers have developed a breath test to identify the presence of hydrogen sulfide among gases present in patients with diarrhea. The program has applied for patents for a four-gas breath test device, which is expected to be available to patients by the end of 2018.

4. The MAST team also developed Lotus, a system designed to safely and precisely collect samples from patients' small intestines. Cedars-Sinai licensed the technology to Stafford Springs, Conn.-based Hobbs Medical, an endoscopy accessories manufacturer and supplier.

Here is more information on the MAST program.

More articles on gastroenterology:

GI leader to know: Dr. Mark Bronner of Louisville Gastroenterology Associates

Beating CRC, one test at a time — Exact Sciences' Mark Stenhouse stumps for Cologuard

5 most read GI/endoscopy stories: June 18-22

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Learning Opportunities

Featured Webinars

Featured Whitepapers

Featured Podcast